-
CME
FDA Safety Changes: Betoptic S, Fragmin, Doxil
The FDA has approved revisions to the safety labeling for betaxolol HCl 0.25% topical ophthalmic drops, dalteparin sodium subcutaneous injection, and doxorubicin HCI liposome injection.
Medscape Medical News, September 2007
-
CME
Pegaptanib and Ranibizumab Slows Progression of Age-Related Macular Degeneration
A systematic review of several randomized controlled trials suggests that both agents seem to slow or stop the progression of neovascular age-related macular degeneration.
Medscape Medical News, September 2007
-
CME/CE
Primary and Secondary Interventions for Diabetic Retinopathy Reviewed
Tight glycemic and blood pressure controls are keys for primary prevention of diabetic retinopathy.
Medscape Medical News, August 2007
-
CME/CE
Problem-Solving Treatment Helps Prevent Depression in Patients With Age-Related Macular Degeneration
This treatment prevented depressive disorders and loss of valued activities in the short term, but these benefits were not maintained over time in patients with age-related macular degeneration.
Medscape Medical News, August 2007
-
CME
Cataracts, Age-Related Macular Degeneration May Predict Mortality
The Blue Mountains Eye Study showed cataracts predict increased mortality in persons aged 49 years or older and age-related macular degeneration helped predict mortality in people aged 49 to 74 years
Medscape Medical News, July 2007
